DCW Ltd
DCW Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
What the Q4 FY26 call signalled
1 of 3 strong
The short version
DCW expects incremental volume growth primarily from C-PVC, where a 10 KT additional volume capacity has recently been commissioned and is expected to scale up quickly, providing annualized benefits. FY27 EBITDA guidance was initially around Rs.400 crores but is now expected to be lower (around Rs.300 crores) due to pricing pressures in commodity and specialty segments.
From DCW Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- DCW expects incremental volume growth primarily from C-PVC, where a 10 KT additional volume capacity has recently been commissioned and is expected to scale up quickly, providing annualized benefits.
- Specialty chemical growth will be focused on related chemistries with synergies in marketing and chemical understanding, rather than broad new chemicals expansion.
- Capacity utilization is near full for most products except C-PVC where further volume growth is possible without immediate new CAPEX.
- Future CAPEX for growth is on hold pending geopolitical developments; current CAPEX mainly targets efficiency improvements in commodities and specialty/niche segments.
2 more points management made on revenue & sales performance
Profitability & Margins
See what DCW Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- DCW Limited is planning future CAPEX primarily in the specialty segment (C-PVC, SIOP, or niche related chemistries) rather than commodity chemicals, where CAPEX will focus more on efficiency rather than volume growth.
- The company has commissioned incremental C-PVC capacity (additional 10 KT) recently and expects to scale up quickly, providing annualized volume and margin benefits.
- They are holding back on announcing major CAPEX currently due to geopolitical uncertainties (e.g., West Asia conflict) and waiting for clearer conditions.
- Legacy loans will be paid off by year-end, improving financial headroom for larger CAPEX in the future.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what DCW Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
DCW Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹609 Cr, net profit ₹18 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What DCW's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Vipul Organics Ltd (Q4 FY26)
Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated) . Key concall takeaways from Vipul Organics's Q4 FY26 earnings call — and how it ranks against…
- Chemfab Alkalis Ltd (Q4 FY26)
Chlor Alkali segment: ₹55.63 crore (down 1.21% YoY from ₹56.31 crore) . Key concall takeaways from Chemfab Alkalis Ltd's Q4 FY26 earnings call — and how it…
- Sudarshan Pharma Industries Ltd (Q4 FY26)
Revenue from Operations for Q4 March 2026: ₹220.92 Cr (Page 41) . Key concall takeaways from Sudarshan Pharma Industries Ltd's Q4 FY26 earnings call — and how…
- Innovassynth Technologies (India) Ltd (Q4 FY26)
Order book improved by approximately INR 60 crore during the quarter, indicating strong customer demand and revenue visibility. Key concall takeaways from…
Frequently Asked Questions
What were DCW Ltd Q4 FY26 results?
DCW expects incremental volume growth primarily from C-PVC, where a 10 KT additional volume capacity has recently been commissioned and is expected to scale up quickly, providing annualized benefits. FY27 EBITDA guidance was initially around Rs.400 crores but is now expected to be lower (around Rs.300 crores) due to pricing pressures in commodity and specialty segments.
What is DCW Ltd share price analysis?
DCW Ltd currently shows a neutral. The stock trades at a P/E of 18.2 with a market cap of ₹1,300 Cr. Investors should review the full earnings analysis for detailed insights.
Is DCW Ltd planning capital expenditure?
DCW Limited is planning future CAPEX primarily in the specialty segment (C-PVC, SIOP, or niche related chemistries) rather than commodity chemicals, where CAPEX will focus more on efficiency rather than volume growth.
Keep DCW Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.